Perspectives
Why Masking Still Needs More Normalization in the US
Masking mandates briefly normalized masks in public, but it is increasingly uncommon to spot mask usage now. Further normalizing masks...
Read more
New RSV and Influenza Vaccine Rollout: Confronting Hesitancy, Supply Constraints, and Ethical Imperatives
A single vial can embody both hope and contention. With the U.S. Centers for Disease Control and Prevention’s recent recommendation...
Read more
Telehealth Policy Cliff Aftermath: Navigating Ethics, Access, and the Quest for Permanence
A single date can unsettle an entire care continuum. On October 1, 2025, the regulatory waivers that underpinned the explosion...
Read more
FDA’s Final AI SaMD Guidance: Where Medical Ethics, Policy, and Patient Experience Converge
A single log entry could spell the difference between trust and trepidation in AI-driven care. As STAT’s “AI Prognosis” newsletter...
Read more
GLP-1 Reimbursement and Access Debates: The Battle Over Coverage Criteria, Prior Authorization, and Equity
A single prior-authorization denial can derail a patient’s treatment plan. In 2025, the soaring use of GLP-1 receptor agonists such...
Read more
Supreme Court Term Rocks Health Law: The Ascendant Role of Religion in American Healthcare
A single opinion can reshape the contours of personal freedom and communal obligation. In its 2025 term, the Supreme Court...
Read more
How To Manage and Overcome a Fear of Childbirth
Are you feeling anxious about giving birth? Learn practical strategies to overcome childbirth fears and feel more confident about your...
Read more
Moderna’s mRNA-1010 Flu Shot Scores Phase 3 Triumph Amid Data Scrutiny and Political Undercurrents
A single datum can reshape public confidence overnight. On June 30, Moderna disclosed that its seasonal influenza candidate, mRNA-1010, achieved...
Read more
One Big Beautiful Bill: A Trillion-Dollar Strike Against Medicaid and Medicare
A single headline can tip the balance of millions of Americans’ access to care. On July 3, the U.S. Senate...
Read more
Milk Under Quarantine: How the H5N1 Dairy-Cow Outbreak Is Stress-Testing U.S. Biosecurity
Milk Under Quarantine Warm forage rarely figures in national conversation; nonetheless, by early July the smell of barn ventilation fans...
Read more
Why Patients Click Play: Trust, Philosophy, and the Allure of Health Videos
A tide of healthcare clips streams unceasingly on smartphones, offering patients bite-sized advice, procedural glimpses, and personal testimonials with the...
Read more
Visible Scars, Invisible Standards: Breast Reduction and the Online Reckoning with Body Image
The Body as Algorithmic Subject The footage begins plainly. A montage of clothing struggles, physical discomfort, and slouched posture. The...
Read more
FDA Evaluation of Certain Bulk Drug Substances in Compounding: Clinical Interpretation
Clinicians increasingly encounter patients using or requesting peptide-based therapies sourced through compounding pharmacies. The U.S. Food and Drug Administration has identified a subset of bulk drug substances, including certain peptides, that may present significant safety risks when used in compounded formulations. The clinical question is whether these regulatory signals reflect meaningful patient-level risk and how they should influence prescribing behavior. This matters because compounded peptides often sit outside traditional approval pathways, creating uncertainty around quality, dosing consistency, and safety. Understanding...
Read morePopular
-
Why Durable Equipment Labels Are Important in Healthcare
-
Undue Burdens of Healthcare Law
-
Managing the Side Effects of Tirzepatide and Semaglutide During Initiation, Dose Escalation, and Exercise Changes
-
Testing from the Living Room: The FDA’s Approval of Teal Health’s At-Home Cervical Cancer Screen Marks a Watershed in Women’s Health
-
When Market Signals Are Ambiguous: The Interpretive Limits of Cross-Benchmark Drug Pricing Analysis
